Fingerprint
Dive into the research topics of 'Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically